Form 8-K - Current report:
SEC Accession No. 0001048477-23-000005
Filing Date
2023-02-27
Accepted
2023-02-27 16:10:29
Documents
14
Period of Report
2023-02-27
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K bmrn-20230227.htm   iXBRL 8-K 33142
2 EX-99.1 earningsrelease-27feb23ex9.htm EX-99.1 340058
6 GRAPHIC bmrnlogoa01a.jpg GRAPHIC 3615
  Complete submission text file 0001048477-23-000005.txt   546753

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT bmrn-20230227.xsd EX-101.SCH 1999
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT bmrn-20230227_lab.xml EX-101.LAB 24132
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT bmrn-20230227_pre.xml EX-101.PRE 12601
8 EXTRACTED XBRL INSTANCE DOCUMENT bmrn-20230227_htm.xml XML 10813
Mailing Address 105 DIGITAL DRIVE NOVATO CA 94949
Business Address 105 DIGITAL DRIVE NOVATO CA 94949 4155066700
BIOMARIN PHARMACEUTICAL INC (Filer) CIK: 0001048477 (see all company filings)

EIN.: 680397820 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-26727 | Film No.: 23674900
SIC: 2834 Pharmaceutical Preparations